Key result
In a 65-year-old man with ischemic heart failure and an initial EF of 15%, PET viability-guided CABG led to clinical stability and an improved EF of 45% at 6 months.
Why the study?
Does PET viability-guided CABG improve ejection fraction and symptoms in a patient with ischemic heart failure and severe left ventricular dysfunction?
Case Report (n=1)
No
Does PET viability-guided CABG improve ejection fraction and symptoms in a patient with ischemic heart failure and severe left ventricular dysfunction?
PET viability imaging can identify patients with severe ischemic heart failure who may derive significant clinical and echocardiographic benefit from high-risk surgical revascularization.
May support PET viability for selecting high-risk CABG candidates in severe ischemic HF; hypothesis-generating, needs prospective validation.
A 65-year-old man presented to his local emergency depart- ment with rapid atrial fibrillation and acute pulmonary edema.This patient had a history of hypertension, and 2 months before this presentation, he developed progressive exertional dyspnea.The patient deteriorated in the emergency department and went into cardiogenic shock.Emergent coronary angiography revealed diffuse 3-vessel disease: a 99% proximal left anterior descending coronary artery lesion, 90% mid-right coronary artery lesion, occluded large first marginal branch, and diffuse severe disease of the left circumflex coronary artery.The initial ejection fraction (EF) on echocardiography was 15%, with mild mitral regurgitation and an estimated pulmonary artery pressure of 55 mm Hg.The patient stabilized with an intraaortic balloon pump and intensive care unit management; however, because of the diffuse nature of the disease, he was not believed to be a surgical candidate.He was transferred to another tertiary-care facility for consideration of cardiac transplantation.As part of this evaluation, a PET viability study was done that demonstrated a significant area of perfusion-metabolism mismatch in the entire anteriolateral wall.Less than 1% of the myocardium was scar, and 28% was defined as hibernating (Figure 1). Response by Velazquez on p 270The results of the viability test were pivotal in the decision to perform coronary artery bypass graft (CABG) surgery in a patient who otherwise would not have had surgery.Approximately 2 months after his initial presentation, the patient had a 4-vessel CABG.His predischarge echocardiogram demonstrated an EF of 25%.Six months after surgery, the patient was clinically stable with New York Heart class II functional symptoms and an EF of 45%.
No takes yet. Share an insight, caveat, or question.
Mielniczuk et al. (2012) conducted a case report in Ischemic heart failure and cardiogenic shock (n=1). PET viability-guided coronary artery bypass graft (CABG) surgery was evaluated on Clinical stability and ejection fraction improvement. In a 65-year-old man with ischemic heart failure and an initial EF of 15%, PET viability-guided CABG led to clinical stability and an improved EF of 45% at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: